Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in GRAL — GRAIL, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in GRAL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$10,601,989
-$5,150,488 QoQ
Shares Held
155,295
-49.1% QoQ
Ownership
0.348%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#32
of 367 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GRAL Over Time

Shares Held

Position Value (USD)

Derivatives in GRAL

reported options exposure · as of Jun 30, 2026
CallValue
$25,396,440
CallShares
372,000
PutValue
$24,563,546
PutShares
359,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $353,545,868 across 33 Diagnostics & Research names. GRAL ranks #8 (3.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 GRAL
GRAIL, Inc.
This page
155,295 $10,601,989

All Filings in GRAL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $24,563,546 359,800
2026-06-30 $25,396,440 372,000
2026-06-30 $10,601,989 155,295
2026-03-31 $17,457,504 337,800
2026-03-31 $23,969,184 463,800
2026-03-31 $15,752,477 304,808
2025-12-31 $1,566,981 18,308
2025-12-31 $28,638,414 334,600
2025-12-31 $73,016,829 853,100
2025-09-30 $7,757,856 131,200
2025-09-30 $37,819,548 639,600
2025-09-30 $417,162 7,055
2025-06-30 $2,202,627 42,836
2025-06-30 $42,817,434 832,700
2025-06-30 $18,624,324 362,200
2025-03-31 $4,203,884 164,600
2025-03-31 $5,365,954 210,100
2025-03-31 $9,527,620 373,047
2024-12-31 $530,859 29,740
2024-12-31 $4,346,475 243,500
2024-12-31 $928,200 52,000
2024-09-30 $1,338,848 97,300
2024-09-30 $2,008,960 146,000
2024-09-30 $2,186,312 158,889
2024-06-30 $2,496,072 162,399